Biber S, Pospiech H, Gottifredi V, Wiesmuller L
Nucleic Acids Res. 2020; 48(21):12188-12203.
PMID: 33166398
PMC: 7708082.
DOI: 10.1093/nar/gkaa974.
Saribas S, Safak M
Viruses. 2020; 12(10).
PMID: 33092197
PMC: 7594058.
DOI: 10.3390/v12101192.
Pinto E, Figueiredo B, Chen W, Galvao H, Formiga M, Fragoso M
Sci Adv. 2020; 6(26):eaba3231.
PMID: 32637605
PMC: 7314530.
DOI: 10.1126/sciadv.aba3231.
Pannkuk E, Laiakis E, Ake P, Strawn S, Wang Y, Fornace Jr A
Metabolites. 2020; 10(6).
PMID: 32521675
PMC: 7345090.
DOI: 10.3390/metabo10060234.
Zambetti G
J Mol Cell Biol. 2019; 11(7):620-623.
PMID: 31310653
PMC: 6735693.
DOI: 10.1093/jmcb/mjz073.
From uncertainty to pathogenicity: clinical and functional interrogation of a rare in-frame deletion.
Quinn E, Maciaszek J, Pinto E, Phillips A, Berdy D, Khandwala M
Cold Spring Harb Mol Case Stud. 2019; 5(4).
PMID: 30886117
PMC: 6672031.
DOI: 10.1101/mcs.a003921.
CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer.
Bhattacharyya S, Sekar V, Majumder B, Mehrotra D, Banerjee S, Bhowmick A
Cell Oncol (Dordr). 2017; 40(2):145-155.
PMID: 28039610
DOI: 10.1007/s13402-016-0311-7.
The Transactivation Domains of the p53 Protein.
Raj N, Attardi L
Cold Spring Harb Perspect Med. 2016; 7(1).
PMID: 27864306
PMC: 5204331.
DOI: 10.1101/cshperspect.a026047.
Two p53 tetramers bind one consensus DNA response element.
Kearns S, Lurz R, Orlova E, Okorokov A
Nucleic Acids Res. 2016; 44(13):6185-99.
PMID: 27034469
PMC: 5291249.
DOI: 10.1093/nar/gkw215.
The p53 circuit board.
Sullivan K, Gallant-Behm C, Henry R, Fraikin J, Espinosa J
Biochim Biophys Acta. 2012; 1825(2):229-44.
PMID: 22333261
PMC: 3307870.
DOI: 10.1016/j.bbcan.2012.01.004.
p53 requires an intact C-terminal domain for DNA binding and transactivation.
Kim H, Kim K, Choi J, Heo K, Baek H, Roeder R
J Mol Biol. 2011; 415(5):843-54.
PMID: 22178617
PMC: 3267882.
DOI: 10.1016/j.jmb.2011.12.001.
Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML.
Link D, Schuettpelz L, Shen D, Wang J, Walter M, Kulkarni S
JAMA. 2011; 305(15):1568-76.
PMID: 21505135
PMC: 3170052.
DOI: 10.1001/jama.2011.473.
Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes.
Gomes N, Espinosa J
Cell Cycle. 2010; 9(17):3428-37.
PMID: 20818159
PMC: 3047614.
DOI: 10.4161/cc.9.17.12998.
Discovering multiple realistic TFBS motifs based on a generalized model.
Chan T, Li G, Leung K, Lee K
BMC Bioinformatics. 2009; 10:321.
PMID: 19811641
PMC: 2770069.
DOI: 10.1186/1471-2105-10-321.
Identification of a novel TP53 germline mutation E285V in a rare case of paediatric adrenocortical carcinoma and choroid plexus carcinoma.
Russell-Swetek A, West A, Mintern J, Jenkins J, Rodriguez-Galindo C, Ribeiro R
J Med Genet. 2008; 45(9):603-6.
PMID: 18762572
PMC: 3487594.
DOI: 10.1136/jmg.2008.059568.
Reversal of 5-flouroucial resistance by adenovirus-mediated transfer of wild-type p53 gene in multidrug-resistant human colon carcinoma LoVo/5-FU cells.
Yu Z, Zhao P, Liu M, Dong X, Tao J, Yao X
World J Gastroenterol. 2004; 10(13):1979-83.
PMID: 15222051
PMC: 4572245.
DOI: 10.3748/wjg.v10.i13.1979.
Comparison of the Rta/Orf50 transactivator proteins of gamma-2-herpesviruses.
Damania B, Jeong J, Bowser B, DeWire S, Staudt M, Dittmer D
J Virol. 2004; 78(10):5491-9.
PMID: 15113928
PMC: 400334.
DOI: 10.1128/jvi.78.10.5491-5499.2004.
Regions and activities of simian virus 40 T antigen that cooperate with an activated ras oncogene in transforming primary rat embryo fibroblasts.
Beachy T, Cole S, Cavender J, Tevethia M
J Virol. 2002; 76(7):3145-57.
PMID: 11884539
PMC: 136032.
DOI: 10.1128/jvi.76.7.3145-3157.2002.
An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.
Ribeiro R, Sandrini F, Figueiredo B, Zambetti G, Michalkiewicz E, Lafferty A
Proc Natl Acad Sci U S A. 2001; 98(16):9330-5.
PMID: 11481490
PMC: 55420.
DOI: 10.1073/pnas.161479898.
DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53.
Nagashima M, Shiseki M, Miura K, Hagiwara K, Linke S, Pedeux R
Proc Natl Acad Sci U S A. 2001; 98(17):9671-6.
PMID: 11481424
PMC: 55510.
DOI: 10.1073/pnas.161151798.